62
Participants
Start Date
June 19, 2020
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
Copanlisib
Copanlisib vials 60 mg
R-CHOP Chemotherapy
Immunochemotherapy
Klinikum-Bremen-Mitte, Bremen
St.-Johannes-Hospital Dortmund, Dortmund
University Hospital Muenster, Münster
University Hospital RWTH Aachen, Aachen
Westpfalz-Klinikum, Kaiserslautern
Hospital Stuttgart - Stuttgart Cancer Center, Stuttgart
Hospital of the Ludwig-Maximilians-University (LMU) Munich, Munich
ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut
University Hospital Ulm, Ulm
Onkozentrum Dresden, Dresden
University Hospital Halle, Halle
University Hospital Leipzig, Leipzig
Collaborators (1)
Bayer
INDUSTRY
University Hospital Muenster
OTHER